Health
TGA investigates Guillain-Barre Syndrome diagnoses after AstraZeneca – The Australian
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians…
The medical regulatory agency has launched an investigation after eight cases of a rare illness that can leave patients paralysed were diagnosed in Australians after they had the AstraZeneca vaccine.
“A possible link between Guillain-Barre Syndrome (GBS) and the AstraZeneca COVID-19 vaccine remains under investigation in Australia and internationally,” the TGA said.
“As of 19 May 2021, we have received eight reports of GBS in patients vaccinated with the AstraZeneca COVID-19 vaccine.
“The TGA continues…
-
General18 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General23 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Business22 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?
-
Noosa News23 hours agoThree steps Queensland SES want you to know to Get Ready for severe weather